Lightnews — Scholar-powered news

AI Proteins @aiproteins.com · Sep 3

We're #hiring a Scientist in Mass Spectrometry!

Apply today or share this post with your network: www.linkedin.com/jobs/view/42...
(ignore what linkedin says - the search is still open)

Interested? Please email your CV to: [email protected]

AI Proteins hiring Scientist in Mass Spectrometry Miniproteins and Bioconjugates in Greater Boston | LinkedIn

Posted 8:20:30 PM. The Company:AI Proteins is a Boston-based biotechnology company focused on the de novo design and…See this and similar jobs on LinkedIn.

www.linkedin.com

1

AI Proteins @aiproteins.com · Aug 26

His expertise and leadership are essential as we continue to industrialize our design-build-test process for drug discovery and work to bring #miniprotein medicines to patients across many diseases.

1

AI Proteins @aiproteins.com · Aug 26

James has been a pivotal force in building our protein engineering approach, and as #CTO, he'll be driving the expansion of our core technology platform, integrating machine learning, synthetic biology, robotics, and large-scale data analysis to create entirely novel protein therapeutics

1 1

AI Proteins @aiproteins.com · Aug 26

Congratulations to Dr. James Bowman on his promotion to Chief Technology Officer!

www.businesswire.com/news/home/20...

www.businesswire.com

1 1 1

Reposted by AI Proteins

Chris Bahl @cdbahl.com · Aug 26

I am overjoyed to announce that James Bowman has been promoted to Chief Technology Officer at @aiproteins.com!

🧵👇

1 1 7

Reposted by AI Proteins

Institute for Protein Innovation @ipiproteins.bsky.social · May 1

#IPISeminar alert 🔔 Friday at 2 p.m. ET, Chris Bahl of AI Proteins will share the challenges of incorporating #artificialintelligence into #proteindesign & the impact reimagined #miniproteins can have on therapeutics. Join us through the QR code or follow the Zoom link on our calendar! rb.gy/xcee9l

2 2

Reposted by AI Proteins

Chris Bahl @cdbahl.com · Apr 15

It was an honor to speak from the main stage at TED last week about our work at AI Proteins

Our mission is to design the next generation of therapeutics built from de novo #miniproteins, and this was an unbelievable opportunity to help shape the broader conversation about the future of biologics

1 1 6

AI Proteins @aiproteins.com · Feb 12

Welcome Phil Brandish, Chief Development Officer, to the AI Proteins team!

www.businesswire.com/news/home/20...

AI Proteins Appoints Philip E. Brandish, PhD as Chief Development Officer

AI Proteins, Inc., a pioneering company utilizing artificial intelligence to design novel miniprotein therapeutics, today announced the appointment of

www.businesswire.com

1

AI Proteins @aiproteins.com · Jan 7

We're delighted to share that our #Founder Chris Bahl @cdbahl.bsky.social is now our CEO!

Chris Bahl @cdbahl.com · Jan 7

I’m excited to share that I am now the CEO of AI Proteins @aiproteins.bsky.social! I’m grateful to continue leading this exceptional team as we build upon the strong foundation that we’ve established since launching the company in 2021.

www.businesswire.com/news/home/20...

🧵👇

AI Proteins Appoints Founder Dr. Chris Bahl as Chief Executive Officer; Company to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week

AI Proteins, Inc., a pioneering company utilizing artificial intelligence to design novel protein therapeutics, announces the appointment of its found

www.businesswire.com

3

Reposted by AI Proteins

Chris Bahl @cdbahl.com · Dec 20

So, I might have ended up on the jumbotron at the Celtics game proudly wearing my @aiproteins.bsky.social colors

1 10

AI Proteins @aiproteins.com · Dec 17

Mireia Solà Colom, Head of Immunotherapeutics at AI Proteins, presents our latest progress on the design and optimization of immune cell engagers built from our de novo #miniproteins

Boston Protein Design and Modeling Club @bpdmc.org · Dec 16

for the folks who weren't able to join for the brilliant presentation by Mireia Solà Colom last week to cap off our 2024 seminar series, you can check out the recording 👇
youtu.be/e6oZgGWjD_0

De novo design of miniprotein-based natural killer cell engagers

YouTube video by Boston Protein Design and Modeling Club

youtu.be

1 3

AI Proteins @aiproteins.com · Dec 3

and more coverage from Endpoints News @endpts.com

endpts.com/bms-inks-dea...

BMS inks deal with AI Proteins; Terns’ early-stage leukemia data

Bristol Myers Squibb partners with AI Proteins for miniprotein development, with up to $400M in milestones. Terns Pharmaceuticals reports positive Phase 1 data for TERN-701. Six biotechs seek Hong Kon...

endpts.com

1 2

Reposted by AI Proteins

Maru Llases @mellases.bsky.social · Dec 3

Exciting times at @aiproteins.bsky.social ! We are getting so close to see our drugs helping patients!
www.fiercebiotech.com/biotech/bris...

Bristol Myers Squibb taps AI Proteins in drug discovery collaboration worth up to $400M

Bristol Myers Squibb has

www.fiercebiotech.com

3 5

AI Proteins @aiproteins.com · Dec 3

You can read more about our exciting new collaboration with Bristol Myers Squibb in this coverage from Fierce Biotech
www.fiercebiotech.com/biotech/bris...

Bristol Myers Squibb taps AI Proteins in drug discovery collaboration worth up to $400M

Bristol Myers Squibb has

www.fiercebiotech.com

1 1 3

AI Proteins @aiproteins.com · Dec 3

AI Proteins is excited to partner with @bms-news.bsky.social to develop novel miniprotein-based therapeutics. This collaboration will leverage our cutting-edge AI-driven platform to design and optimize miniproteins with the potential to transform patient outcomes
www.businesswire.com/news/home/20...

AI Proteins Announces Research Collaboration and Option Agreement with Bristol Myers Squibb for Miniprotein-Based Therapeutics Valued up to $400M

AI Proteins, Inc., a biotechnology company that utilizes computational de novo protein design to create therapeutic miniproteins, today announced that

www.businesswire.com

1 2 3

Reposted by AI Proteins

Chris Bahl @cdbahl.com · Dec 3

We've got some very exciting news to share!

businesswire.com/news/home/20...

and here's a 🧵 about the journey from academia to
@aiproteins.bsky.social

AI Proteins Announces Research Collaboration and Option Agreement with Bristol Myers Squibb for Miniprotein-Based Therapeutics Valued up to $400M

AI Proteins, Inc., a biotechnology company that utilizes computational de novo protein design to create therapeutic miniproteins, today announced that

businesswire.com

1 1 9

AI Proteins @aiproteins.com · Nov 25

We're excited that Mireia Solà Colom, our Head of Immunotherapeutics will share some of our latest work on immune cell engagers at @bpdmc.bsky.social next month!

Boston Protein Design and Modeling Club @bpdmc.org · Nov 22

There's just one meeting left in 2024, and we have a spectacular seminar by Mireia Solà Colom lined up for you! Join us at 7pm in Room 181, Building 68, MIT on Wednesday, December 11th.

"De novo design of miniprotein-based natural killer cell engagers"

See you there & Happy Thanksgiving!
bpdmc.org

schedule

introduction and membership Boston Protein Design and Modeling Club (BPDMC) is a community of computational protein engineers and modelers from both academia and industry. While we are based in Boston...

bpdmc.org

1 3

AI Proteins @aiproteins.com · Nov 16

Our founder, President and CSO Chris Bahl @cdbahl.bsky.social went to the Falling Walls Science Summit last week to explain how we make #miniprotein therapeutics with unprecedented ability to control cellular behavior - you can check out the recording 👇
www.youtube.com/live/zB6-iUB...

YouTube

Share your videos with friends, family, and the world

www.youtube.com

1 3